Prolonged Blood-Brain Barrier Injury Occurs After Experimental Intracerebral Hemorrhage and Is Not Acutely Associated with Additional Bleeding.
Colby A NadeauKristen DietrichCassandra M WilkinsonAndrew M CrawfordGraham N GeorgeHelen K NicholFrederick ColbournePublished in: Translational stroke research (2018)
Intracerebral hemorrhage (ICH) causes blood-brain barrier (BBB) damage along with altered element levels in the brain. BBB permeability was quantified at 3, 7, and 14 days with Evans Blue dye after collagenase-induced ICH in rat. At peak permeability (day 3), a gadolinium (Gd)-based contrast agent was injected to further characterize BBB disruption, and X-ray fluorescence imaging (XFI) was used to map Gd, Fe, Cl, and other elements. XFI revealed that Ca, Cl, Gd, and Fe concentrations were significantly elevated, whereas K was significantly decreased. Therefore, using Gd-XFI, we co-determined BBB dysfunction with alterations in the metallome, including those that contribute to cell death and functional outcome. Warfarin was administered 3 days post-ICH to investigate whether additional or new bleeding occurs during peak BBB dysfunction, and hematoma volume was assessed on day 4. Warfarin administration prolonged bleeding time after a peripheral cut-induced bleed, but warfarin did not worsen hematoma volume. Accordingly, extensive BBB leakage occurred after ICH, but did not appear to affect total hematoma size.
Keyphrases
- blood brain barrier
- atrial fibrillation
- cerebral ischemia
- oxidative stress
- fluorescence imaging
- cell death
- direct oral anticoagulants
- high glucose
- diabetic rats
- venous thromboembolism
- oral anticoagulants
- brain injury
- endothelial cells
- magnetic resonance
- photodynamic therapy
- high resolution
- contrast enhanced
- multiple sclerosis
- magnetic resonance imaging
- resting state
- computed tomography
- signaling pathway